Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 33.24
+0.32 (0.97%)
Jun 26, 2025, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 4.86 billion as of June 26, 2025. Its market cap has increased by 64.43% in one year.
Market Cap
4.86B
Enterprise Value
3.24B
Revenue
511.66M
Ranking
n/a
PE Ratio
35.76
Stock Price
33.24
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 4.86B, a decrease of -40.88%. That is a compound annual growth rate of -12.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 4.86B | 40.89% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 351.36B |
| Shenzhen Mindray Bio-Medical Electronics | 277.01B |
| WuXi AppTec | 189.78B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.15B |
| Sichuan Biokin Pharmaceutical | 119.86B |
| Aier Eye Hospital Group | 115.64B |
| Shanghai United Imaging Healthcare | 105.68B |
| Yunnan Baiyao Group Co.,Ltd | 99.67B |